Rapid metastatic progression of primary pulmonary synovial sarcoma despite guideline-concordant multimodal therapy: a case report - Summary - MDSpire

Accelerated metastatic development of primary pulmonary synovial sarcoma despite adherence to multimodal treatment guidelines: a case study

  • By

  • Samson Mumber

  • Lindsey Kuipers

  • John Mumber

  • Melissa Dillmon

  • Matthew Mumber

  • July 21, 2026

Share

Objective:

To report a case of primary pulmonary synovial sarcoma (PPSS) in a 60-year-old woman with an atypical presentation and highlight its aggressive clinical course despite multimodal therapy.

Approach:
  • Case Presentation: A 60-year-old woman with a significant smoking history presented with gross hematuria and was found to have a right lower lobe lung mass. Initial imaging and biopsy confirmed PPSS.
  • Treatment: The patient underwent neoadjuvant chemotherapy followed by surgical resection. Despite initial tumor reduction and negative margins, she experienced rapid metastatic progression.
Key Findings:
  • PPSS accounts for less than 0.5% of all primary lung malignancies and is characterized by a specific chromosomal translocation, t(X;18)(p11;q11).
  • The patient showed initial response to neoadjuvant chemotherapy but developed widespread metastases shortly after surgery.
Interpretation:

The case illustrates the aggressive nature of PPSS and the potential for rapid disease progression despite multimodal treatment.

Limitations:
  • The rarity of PPSS limits the generalizability of findings based on a single case report.
  • The case is based on a single patient experience.
Conclusion:

Recurrence and metastasis are common in PPSS even after apparent initial response to therapy, indicating a need for improved targeted therapies.

Original Source(s)

Related Content